Genetic polymorphisms of CYP2C19 and effect of CYP2C19☆2 allele on clopidogrel P2Y12 inhibition in healthy Malaysian volunteers

被引：0
|
作者：
Sani, Y. N. [1 ]
Lim, S. C. [1 ]
Lim, L. H. [1 ]
Edwin, N. E. Y. [1 ]
Khan, N. Abdul Karim [1 ]
Goh, T. H. [2 ]
Serebruany, V. L. [3 ]
Yuen, K. H. [1 ]
机构：
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Loh Guan Lye Specialists Ctr, George Town, Malaysia
[3] Johns Hopkins Univ, Towson, MD USA
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：874 / 874
页数：1
相关论文
共 50 条
  • [41] CYP2C19 Genotype and Outcomes of Clopidogrel Treatment
    Geisler, Tobias
    Bigalke, Boris
    Schwab, Matthias
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (05): : 481 - 481
  • [42] The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway
    Ford, Neville F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1474 - 1483
  • [43] Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin
    Ibeanu, GC
    Goldstein, JA
    Meyer, U
    Benhamou, S
    Bouchardy, C
    Dayer, P
    Ghanayem, BI
    Blaisdell, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (03): : 1490 - 1495
  • [44] Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers
    Can-Jun Ruan
    Dong-Yang Liu
    Ji Jiang
    Pei Hu
    European Journal of Clinical Pharmacology, 2012, 68 : 1677 - 1680
  • [45] Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers
    Ruan, Can-Jun
    Liu, Dong-Yang
    Jiang, Ji
    Hu, Pei
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (12) : 1677 - 1680
  • [46] Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms
    Chen, Bi-Lian
    Zhang, Wei
    Li, Qing
    Li, Ya-Lin
    He, Yi-Jing
    Fan, Lan
    Wang, Lian-Sheng
    Liu, Zhao-Qian
    Zhou, Hong-Hao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (08) : 904 - 908
  • [47] Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
    Kang, Pureum
    Cho, Chang-Keun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    Choi, Chang-Ik
    Bae, Jung-Woo
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (05) : 438 - 447
  • [48] Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
    Pureum Kang
    Chang-Keun Cho
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Chang-Ik Choi
    Jung-Woo Bae
    Archives of Pharmacal Research, 2023, 46 : 438 - 447
  • [49] Baseline P2Y12 reactivity, kidney function, and CYP2C19 genotype determine clopidogrel responsiveness in acute stroke
    Lee, Yi-Chung
    Liao, Yi-Chu
    Lin, Chun-Jen
    Chung, Chih-Ping
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [50] The effect of CYP2C19*2 polymorphism on clopidogrel resistance in COPD patients
    Kilik, Zeliha Funda
    Akalin, Hilal
    Bayramov, Ruslan
    Erdem, Yakut
    Dundar, Munis
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S80 - S80
12345